Akari Therapeutics Announces Merger Approval With Peak Bio

AlloVir and Kalaris Therapeutics To Merge

Alexandria Venture Investments Join $10M Seed Financing For CrossBridge Bio

Alexandria Venture Investments Join $115 Million Series A For Axonis Therapeutics

Alexandria Venture Investments Joins $45M Financing For Leal Therapeutics

Hello Heart Appoints Bill Otten As Commercial President

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer

Biocom California Names the Ninth Annual Life Science Catalyst Award Winners

Interview with Adam Low, CEO of SENTA Partners

Meridian Purchases Medical Office Building for $8.05 Million in Tucson

Nodenza Venture Partners Invests In Trellis Bioscience

CARPL.ai Secures CE Mark for Radiology AI Platform, Expands Reach in Europe

RXNT Acquires Scalabull

NaNotics Selected for Space-H Accelerator to Explore Astronaut Disease Treatment in Space

Lyra Health and Hazelden Betty Ford Foundation Announce Comprehensive Care Program

New Carta Healthcare Survey Finds Majority of Clinical Data Abstractors Are Eager for Automation